• Suzette Matthijsse

Suzette Matthijsse, PhD has a diverse work history with a focus on health economics analysis and modeling. • Suzette is currently the EU Head of Modelling and Analytics at Lumanity, leading a team of health economists, statisticians, and advanced analytics specialists based in the Netherlands, Ireland, and the UK. In this role, they are responsible for the M&A Global Service Strategy and BD operations. Prior to this, they held positions at BresMed, where they served as the EU Head of Health Economics Analysis and a Director. • Suzette provided strategic advice to the teams and clients, supported recruitment and business development, and worked on international modeling projects in various therapeutic areas. Before joining BresMed, Suzette worked as a scientific researcher at Erasmus MC, focusing on cervical cancer and HPV vaccination. • Suzette also has teaching and research experience at Utrecht University and has worked in financial administration and home care roles.

Suzette Matthijsse, PhD completed their education in a chronological order as follows:

• Suzette obtained a Doctor of Philosophy (PhD) degree in Public Health from Erasmus University Rotterdam, where they studied from an unknown start year until 2017.

In 2009 to 2011, Suzette pursued a Master of Science (MS) degree in Methodology and Statistics of Behavioral and Social Sciences from the Graduate School of Utrecht University.

From 2011 to 2012, they attended Erasmus University Rotterdam to earn a second Master of Science (MS) degree with a specialization in Public Health within the field of Health Sciences.

In 2006 to 2009, Suzette completed a Bachelor of Science (BS) degree in Psychology at Utrecht University.

• Suzette'ssecondary education includes attending Revius Lyceum Doorn from 2000 to 2006, where they obtained a Gymnasium degree. No field of study is mentioned for this degree.

Additionally, they obtained certification in "Dale Carnegie Sales Training: Winning with Relationship Selling" from Dale Carnegie Training in May 2022.